France· FR:61396856
GLYCEROPHOSPHATE DE SODIUM KABI 216 mg/mL (1 mmol/mL), solution à diluer pour perfusion
A medicinal product containing glycérophosphate de sodium pentahydraté, registered in France by FRESENIUS KABI FRANCE, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- GLYCÉROPHOSPHATE DE SODIUM PENTAHYDRATÉ
- Manufacturer
- FRESENIUS KABI FRANCE
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip13340093028862720 ampoules polypropylène de 20 mLEUR 157.34
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Glycérophosphate de sodium pentahydraté in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumGlycophos 20 mlFresenius Kabi
- PolandGlycophosFresenius Kabi AB
- United KingdomGlycophos 4.32g/20ml concentrate for solution for infusion vialsFresenius Kabi Ltd
- FinlandGlycophosFresenius Kabi AB
- CzechiaSODIUM GLYCEROPHOSPHATE FRESENIUSFresenius Kabi s.r.o., Praha
- NorwayGlycophosFresenius Kabi
- GermanyNatriumglycerophosphat-Ampulle FreseniusFresenius Kabi Deutschland Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 19 EEA countries. Names it is sold under:
- Austria · Glycophos
- Belgium · Glycophos
- Cyprus · Glycophos
- Czechia · Sodium Glycerophosphate Fresenius
- Germany · Natriumglycerophosphat-Ampulle Fresenius
- Denmark · Glycophos
- Spain · Glycophos
- Finland · Glycophos
- Greece · Glycophos
- Hungary · Nátrium-Glicerin-Foszfát Fresenius
- Italy · Glycophos
- Lithuania · Glycophos
- Latvia · Glycophos
- Netherlands · Glycophos
- Poland · Glycophos
- Portugal · Glycophos
- Romania · Glycophos
- Sweden · Glycophos
- Slovakia · Sodium Glycerophosphate Fresenius
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a973263c-f25e-41b5-8baf-8d81f749a03c GET /v1/drugs/a973263c-f25e-41b5-8baf-8d81f749a03c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "61396856",
"date_amm": "2024-04-04",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "GLYCÉROPHOSPHATE DE SODIUM PENTAHYDRATÉ",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution à diluer pour perfusion",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about glycérophosphate de sodium pentahydraté.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.